Sandra Nishikawa

1.0k total citations
18 papers, 815 citations indexed

About

Sandra Nishikawa is a scholar working on Infectious Diseases, Genetics and Molecular Biology. According to data from OpenAlex, Sandra Nishikawa has authored 18 papers receiving a total of 815 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in Sandra Nishikawa's work include Viral gastroenteritis research and epidemiology (7 papers), Virus-based gene therapy research (7 papers) and Cancer Research and Treatments (4 papers). Sandra Nishikawa is often cited by papers focused on Viral gastroenteritis research and epidemiology (7 papers), Virus-based gene therapy research (7 papers) and Cancer Research and Treatments (4 papers). Sandra Nishikawa collaborates with scholars based in Canada, China and United States. Sandra Nishikawa's co-authors include Kensuke Hirasawa, Patrick W.K. Lee, Kara L. Norman, Tommy Alain, Anna E. Kossakowska, Matthew Coffey, Douglas J. Demetrick, Lisa Difrancesco, James E. Strong and David M. Waisman and has published in prestigious journals such as Blood, PLoS ONE and Development.

In The Last Decade

Sandra Nishikawa

18 papers receiving 798 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra Nishikawa Canada	13	615	334	276	212	185	18	815
Stephanie M. Oberhaus United States	12	379 0.6×	465 1.4×	362 1.3×	83 0.4×	45 0.2×	15	970
Dominic G. Roy Canada	18	708 1.2×	152 0.5×	466 1.7×	644 3.0×	164 0.9×	31	1.2k
Alexander Pereboev United States	21	481 0.8×	145 0.4×	475 1.7×	351 1.7×	50 0.3×	36	962
Murielle Gantzer France	8	620 1.0×	127 0.4×	544 2.0×	400 1.9×	77 0.4×	13	915
Feorillo Galivo United States	17	1.0k 1.7×	186 0.6×	443 1.6×	706 3.3×	156 0.8×	21	1.3k
Rae Myers United States	14	709 1.2×	141 0.4×	253 0.9×	264 1.2×	89 0.5×	15	846
Tsanan Giroglou Germany	12	414 0.7×	177 0.5×	379 1.4×	156 0.7×	41 0.2×	17	730
Mary Harvey United States	11	688 1.1×	154 0.5×	256 0.9×	216 1.0×	73 0.4×	14	889
Mohan Kuppuswamy United States	13	816 1.3×	179 0.5×	677 2.5×	388 1.8×	135 0.7×	20	977
Jennifer M Paterson Canada	5	956 1.6×	232 0.7×	447 1.6×	521 2.5×	151 0.8×	6	1.2k

Countries citing papers authored by Sandra Nishikawa

Since Specialization

Citations

This map shows the geographic impact of Sandra Nishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Nishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Nishikawa more than expected).

Fields of papers citing papers by Sandra Nishikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Nishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Nishikawa. The network helps show where Sandra Nishikawa may publish in the future.

Co-authorship network of co-authors of Sandra Nishikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Nishikawa. A scholar is included among the top collaborators of Sandra Nishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Nishikawa. Sandra Nishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Mori, Yoshinori, et al.. (2023). Modulation of Reoviral Cytolysis (I): Combination Therapeutics. Viruses. 15(7). 1472–1472. 1 indexed citations

Zhou, Rongyan, et al.. (2019). Post-Passage rock inhibition induces cytoskeletal aberrations and apoptosis in Human embryonic stem cells. Stem Cell Research. 41. 101641–101641. 20 indexed citations

Nishikawa, Sandra, Shan Gao, Markus Czub, et al.. (2015). Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals. PLoS ONE. 10(9). e0137568–e0137568. 13 indexed citations

Coffin, Carla S., Patricia M. Mulrooney‐Cousins, Carla Osiowy, et al.. (2014). Virological characteristics of occult hepatitis B virus in a North American cohort of human immunodeficiency virus type 1-positive patients on dual active anti-HBV/HIV therapy. Journal of Clinical Virology. 60(4). 347–353. 19 indexed citations

Coffin, Carla S., Carla Osiowy, Shan Gao, et al.. (2014). Hepatitis B virus (HBV) variants fluctuate in paired plasma and peripheral blood mononuclear cells among patient cohorts during different chronic hepatitis B (CHB) disease phases. Journal of Viral Hepatitis. 22(4). 416–426. 29 indexed citations

Geransar, Rose, et al.. (2013). NO–β-catenin crosstalk modulates primitive streak formation prior to embryonic stem cell osteogenic differentiation. Development. 140(4). e406–e406. 1 indexed citations

Sharma, Navneet, Bernard Renaux, Mahmoud Saifeddine, et al.. (2013). Implantation serine proteinase 2 is a monomeric enzyme with mixed serine proteolytic activity and can silence signalling via proteinase activated receptors. Biochemistry and Cell Biology. 91(6). 487–497. 1 indexed citations

Geransar, Rose, et al.. (2012). NO/beta-catenin crosstalk modulates primitive streak formation prior to embryonic stem cell osteogenic differentiation. Journal of Cell Science. 125(Pt 22). 5564–77. 29 indexed citations

Thomas, Bradley, Sandra Nishikawa, Ken‐ichi Ito, et al.. (2011). Peptide vaccination is superior to genetic vaccination using a recombineered bacteriophage λ subunit vaccine. Vaccine. 30(6). 998–1008. 14 indexed citations

10.

Sharma, Navneet, Bernard Renaux, Mahmoud Saifeddine, et al.. (2011). Implantation Serine Proteinase 1 Exhibits Mixed Substrate Specificity that Silences Signaling via Proteinase-Activated Receptors. PLoS ONE. 6(11). e27888–e27888. 5 indexed citations

11.

Thirukkumaran, Chandini M., Kensuke Hirasawa, Joanne Luider, et al.. (2010). Oncolytic Viral Therapy for Prostate Cancer: Efficacy of Reovirus as a Biological Therapeutic. Cancer Research. 70(6). 2435–2444. 78 indexed citations

12.

Yang, Wenqing, Xueqing Lun, Cheryl A. Palmer, et al.. (2004). Efficacy and Safety Evaluation of Human Reovirus Type 3 in Immunocompetent Animals. Clinical Cancer Research. 10(24). 8561–8576. 62 indexed citations

13.

Hirasawa, Kensuke, Sandra Nishikawa, Kara L. Norman, et al.. (2003). Systemic reovirus therapy of metastatic cancer in immune-competent mice.. PubMed. 63(2). 348–53. 124 indexed citations

14.

Alain, Tommy, Kensuke Hirasawa, Sandra Nishikawa, et al.. (2002). Reovirus therapy of lymphoid malignancies. Blood. 100(12). 4146–4153. 94 indexed citations

15.

Norman, Kara L., Matthew Coffey, Kensuke Hirasawa, et al.. (2002). Reovirus Oncolysis of Human Breast Cancer. Human Gene Therapy. 13(5). 641–652. 138 indexed citations

16.

Hirasawa, Kensuke, Sandra Nishikawa, Kara L. Norman, et al.. (2002). Oncolytic reovirus against ovarian and colon cancer.. PubMed. 62(6). 1696–701. 161 indexed citations

17.

Štros, Michal, Sandra Nishikawa, & Gordon H. Dixon. (1994). cDNA sequence and structure of a gene encoding trout testis high‐mobility‐group‐1 protein. European Journal of Biochemistry. 225(2). 581–591. 15 indexed citations

18.

Winkfein, Robert J., Sandra Nishikawa, Wayne Connor, & Gordon H. Dixon. (1993). Characterization of a marsupial sperm protamine gene and its transcripts from the North American opossum (Didelphis marsupialis). European Journal of Biochemistry. 215(1). 63–72. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact